COMMUNIQUÉS West-GlobeNewswire

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

13/02/2024 - 14:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN ◊ 3D [...]

Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

13/02/2024 - 14:00

-First Subject Dosed with BB-301 in Phase 1b/2a Clinical Treatment Study (NCT06185673) in November 2023- -Data Safety Monitoring Board Review for First Subject Completed After Day 28 Study Visit- -Second Subject [...]

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

13/02/2024 - 14:00

One of the largest pharmacy benefit management (PBM) companies in the United States has added VOQUEZNA (vonoprazan) tablets to its national formularies for commercial plans, effective immediately FLORHAM PARK, N.J., Feb [...]

Dr. Lisandro Montalvo-Burke Joins Healthmap Solutions as Medical Director for Puerto Rico

13/02/2024 - 14:00

GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in [...]

DLH to Provide Information Technology Services at National Institute on Drug Abuse

13/02/2024 - 14:00

ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and [...]

Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments

13/02/2024 - 14:00

Jordyn Tarazi joins as Vice President, Investor Relations and Corporate Communications Nikhil Aneja, CPA, CA appointed as Vice President, Finance SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Aligos [...]

Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia

13/02/2024 - 14:00

Tonmya™ is a potential new first-line therapy, non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials New Drug Application (NDA) submission to the [...]

RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations

13/02/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral [...]

Breckenridge Distillery Wins World’s Best Finished Bourbon at 2024 World Whiskies Awards

13/02/2024 - 14:00

Breckenridge Distillery takes home three awards at the 2024 World Whiskies Awards by Whisky Magazine, including World's Best Finished Bourbon, America’s Best Finished Bourbon and Icons of Whisky Campaign Innovator of [...]

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA

13/02/2024 - 14:00

MINNEAPOLIS, Feb. 13, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for [...]

MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY

13/02/2024 - 14:00

San Francisco Fans Nationwide Get Three Free Mangorx ED Pills Based on Sunday’s Game Point Difference Dallas, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“ MangoRx ” or the “Company”), [...]

Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004

13/02/2024 - 13:59

-- Activation of four U.S. sites for Phase 1 clinical trial of PAS-004 to evaluate safety, dose, key biomarker data and preliminary efficacy -- -- Plans to open three additional sites in Eastern Europe in the coming [...]

Ocular Therapeutix™ Announces First Subjects Screened in Phase 3 Pivotal Clinical Trial of AXPAXLI™ in Wet AMD

13/02/2024 - 13:37

Phase 3 SOL-1 study will evaluate the efficacy and safety of AXPAXLI in wet AMD BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the [...]

CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma

13/02/2024 - 13:30

NEEDHAM, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]

Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™

13/02/2024 - 13:30

Approval issued by the Health Authority of Colombia INVIMA for Adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna [...]

Kraig Biocraft Laboratories Announces New Spider Silk Production Facility in Vietnam's Silk Capital

13/02/2024 - 13:05

ANN ARBOR, Mich., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces it has now taken possession of its new recombinant spider silk production [...]

Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility

13/02/2024 - 13:00

Redwood City, California to complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE [...]

LianBio Announces Completion of Strategic Review

13/02/2024 - 13:00

LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividend SHANGHAI, China and PRINCETON, N.J., Feb. 13, [...]

Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung

13/02/2024 - 13:00

• FDA clears IND and Phase 1 (KYANITE-1) clinical trial expected to be initiated in 1H 2024 PITTSBURGH, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage [...]